XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Follow-On Offering
Private Placement
Cumulative effect of accounting changes
Common Stock
Common Stock
Follow-On Offering
Common Stock
Private Placement
Additional paid-in capital
Additional paid-in capital
Follow-On Offering
Additional paid-in capital
Private Placement
Accumulated other comprehensive loss
Accumulated deficit
Accumulated deficit
Private Placement
Accumulated deficit
Cumulative effect of accounting changes
Beginning balance (in shares) at Dec. 31, 2018         250,283,513                  
Beginning balance at Dec. 31, 2018 $ 147,431     $ 107,822 $ 2,502     $ 392,896     $ (29,414) $ (218,553)   $ 107,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 103,096                     103,096    
Other comprehensive income (loss) 5,487                   5,487      
Class B Common Stock follow-on offering, net of expenses (in shares)             64,509              
Class B Common Stock follow-on offering, net of expenses of $12,898     $ 418             $ 466     $ (48)  
Dividends declared (25,390)                     (25,390)    
Profit-sharing plan shares, net (in shares)         (318,203)                  
Profit-sharing plan shares, net (2,417)       $ (3)             (2,414)    
Shares issued in connection with deferred compensation plan, net (in shares)         2,322,983                  
Shares issued in connection with deferred compensation plan, net (5,609)       $ 23             (5,632)    
Deferred compensation plan elective participant deferrals and vesting of awards 3,586             3,586            
Payment of shareholder Put and Call rights (in shares)         (1,126,747)                  
Payment of shareholder Put and Call rights (8,838)       $ (11)             (8,827)    
Stock option exercises, net (in shares)         3,214,542                  
Stock option exercises, net 1,303       $ 33     3,579       (2,309)    
Stock-based compensation expense 8,091             8,091            
Shares related to restricted stock, net (in shares)         395,336                  
Shares related to restricted stock, net (399)       $ 4     (4)       (399)    
Other (in shares)         7,016                  
Other 38             53       (15)    
Ending balance (in shares) at Dec. 31, 2019         254,842,949                  
Ending balance at Dec. 31, 2019 334,619       $ 2,548     408,667     (23,927) (52,669)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 126,521                     126,521    
Other comprehensive income (loss) (2,306)                   (2,306)      
Class B Common Stock follow-on offering, net of expenses (in shares)           9,603,965                
Class B Common Stock follow-on offering, net of expenses of $12,898   $ 294,429 $ (57)     $ 96     $ 294,333       $ (57)  
Dividends declared (424,018)                     (424,018)    
Profit-sharing plan shares, net (in shares)         (549,834)                  
Profit-sharing plan shares, net (6,970)       $ (5)             (6,965)    
Shares issued in connection with deferred compensation plan, net (in shares)         3,081,607                  
Shares issued in connection with deferred compensation plan, net (4,625)       $ 31             (4,656)    
Deferred compensation plan elective participant deferrals and vesting of awards 3,530             3,530            
Payment of shareholder Put and Call rights (in shares)         (128,007)                  
Payment of shareholder Put and Call rights (1,454)       $ (1)             (1,453)    
Stock option exercises, net (in shares)         4,060,839                  
Stock option exercises, net 4,356       $ 41     9,070       (4,755)    
Shares issued for stock grants, net (in shares)         21,956                  
Shares issued for stock grants, net 319             319            
Stock-based compensation expense 25,194             25,194            
Shares related to restricted stock, net (in shares)         1,221,029                  
Shares related to restricted stock, net (7,939)       $ 12     0       (7,951)    
Ending balance (in shares) at Dec. 31, 2020         272,154,504                  
Ending balance at Dec. 31, 2020 341,599       $ 2,722     741,113     (26,233) (376,003)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 93,192                     93,192    
Other comprehensive income (loss) (65,541)                   (65,541)      
Shares issued related to acquisition (in shares)         3,141,342                  
Shares issued related to acquisition 182,390       $ 31     182,359            
Purchase of capped call options, net of tax of $12,871 (38,734)             (38,734)            
Dividends declared (33,537)                     (33,537)    
Shares issued in connection with deferred compensation plan, net (in shares)         2,378,645                  
Shares issued in connection with deferred compensation plan, net (69,007)       $ 24             (69,031)    
Deferred compensation plan elective participant deferrals and vesting of awards 2,619             2,619            
Deferred compensation plan modification (4,739)             (4,739)            
Shares issued in connection with Executive Bonus Plan, net (in shares)         238,755                  
Shares issued in connection with Executive Bonus Plan, net 12,214       $ 2     20,951       (8,739)    
Shares issued in connection with employee stock purchase plan (in shares)         104,716                  
Shares issued in connection with employee stock purchase plan, net 3,408       $ 1     3,845       (438)    
Stock option exercises, net (in shares)         4,587,053                  
Stock option exercises, net (32,180)       $ 46     5,559       (37,785)    
Shares issued for stock grants, net (in shares)         7,824                  
Shares issued for stock grants, net 450             450            
Stock-based compensation expense 24,382             24,382            
Shares related to restricted stock, net (in shares)         (86,120)                  
Shares related to restricted stock, net (7,294)       $ (1)     0       (7,293)    
Ending balance (in shares) at Dec. 31, 2021         282,526,719                  
Ending balance at Dec. 31, 2021 $ 409,222       $ 2,825     $ 937,805     $ (91,774) $ (439,634)